GlassScriptPhysician profile
William D Ulmer
NPI 1528327582
$4,436.36
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $609 · 2021: $855 · 2022: $946 · 2023: $1,139 · 2024: $19.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.10 |
| Education | $164.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $822.39 | 2019-2023 | Erleada |
| Astellas Pharma US INC | $715.75 | 2019-2024 | Xtandi |
| Dendreon Pharmaceuticals LLC | $715.09 | 2019-2023 | Provenge |
| Myovant Sciences INC. | $179.55 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $164.44 | 2019-2022 | |
| Blue Earth Diagnostics | $163.27 | 2019-2022 | |
| Pfizer INC. | $162.01 | 2019-2023 | |
| Amgen INC. | $144.62 | 2019-2023 | Xgeva |
| Merck Sharp & Dohme LLC | $129.54 | 2021-2023 | Lynparza, Keytruda, Welireg |
| Endo Pharmaceuticals INC. | $129.19 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.99 | 2019-2023 | |
| Boston Scientific Corporation | $120.16 | 2020-2022 | |
| Teleflex LLC | $103.58 | 2021-2023 | Urolift |
| Sumitomo Pharma America, INC. | $89.76 | 2023 | Orgovyx |
| Urogen Pharma, INC. | $75.31 | 2023 | Jelmyto |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $72.99 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $64.05 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $60.19 | 2023 | Trelstar |
| Neotract INC. | $60.03 | 2019-2020 | |
| Acerus Pharmaceuticals Corporation | $53.64 | 2020-2022 | |
| Aytu Biopharma, INC. | $51.79 | 2019 | |
| Progenics Pharmaceuticals, INC. | $35.99 | 2022 | |
| Alnylam Pharmaceuticals INC. | $25.60 | 2021 | |
| Laborie Medical Technologies Corp. | $24.95 | 2023 | |
| Genzyme Corporation | $24.12 | 2023 | |
| Abbvie INC. | $23.35 | 2023 | Lupron Depot |
| 180 Medical, INC. | $18.53 | 2019 | |
| Antares Pharma, INC. | $18.21 | 2022 | |
| Coloplast Corp | $17.81 | 2020 | |
| Dentsply Ih INC. | $16.94 | 2019 | |
| Clarus Therapeutics INC. | $16.47 | 2021 | |
| Accord Healthcare, INC. | $15.05 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ulmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.